Lišková Barbora Ph.D.

Lišková Barbora Ph.D.'s picture
Academic Title: Mgr.
Phone: +420-585 63 2181 Office, +420-585 63 2147 Lab

Publications

DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin. Stepankova J, Studenovsky M, Malina J, Kasparkova J, Liskova B, Novakova O, Ulbrich K, Brabec V. Biochem Pharmacol. 2011 Aug 1;82(3):227-35.

 

Cellular response to antitumor cis-Dichlorido platinum(II) complexes of CDK inhibitor Bohemine and its analogues. Liskova B, Zerzankova L, Novakova O, Kostrhunova H, Travnicek Z, Brabec V. Chem Res Toxicol. 2012 Feb 20;25(2):500-9.

 

Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity. Betanzos-Lara S, Novakova O, Deeth RJ, Pizarro AM, Clarkson GJ, Liskova B, Brabec V, Sadler PJ, Habtemariam A. J Biol Inorg Chem. 2012 Oct;17(7):1033-51.

 

Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine. Novakova O, Liskova B, Vystrcilova J, Suchankova T, Vrana O, Starha P, Travnicek Z, Brabec V. Eur J Med Chem. 2014 May 6;78:54-64.

 

Effect of defined green tea extract in various dosage schemes on drug-metabolizing enzymes in mice in vivo. Matouskova P, Bartikova H, Bousova I, Szotakova B, Martin J, Skorkovska J, Hanusova V, Tomankova V, Anzenbacherova E, Liskova B, Anzenbacher P, Skalova L. Journal of functional foods 10 (2014) 327–335

 

Influence of diet supplementation with green tea extract on drug-metabolizing enzymes in a mouse model of monosodium glutamate-induced obesity. Bousova I, Matouskova P, Bartikova H, Szotakova B, Hanusova V, Tomankova V, Anzenbacherova E, Liskova B, Anzenbacher P, Skalova L. Eur J Nutr. 2015 Feb 8. [Epub ahead of print]

 

Altered cytochrome P450 activities and expression levels in liver and intestines of monosodium glutamate-induced mouse model of human obesity. Tomankova V, Liskova B, Skalova L, Bartikova H, Bousova I, Jourova L, Anzenbacher P, Ulrichova J, Anzenbacherova E. Life Sci. 2015 Jul 15;133:15-20. doi: 10.1016/j.lfs.2015.04.014. Epub 2015 May 18.

 

Evaluation of possible inhibition of human liver drug metabolizing cytochromes P450 by two new acetylcholinesterase oxime-type reactivators. Spicakova A, Anzenbacher P, Liskova B, Kuca K, Fusek J, Anzenbacherova E. Food Chem Toxicol. 2016 Feb;88:100-4. doi: 10.1016/j.fct.2015.11.024

 

The reverse role of the hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in the central serotonergic regulation of the liver cytochrome P450 isoform CYP2C11. Rysz M, Bromek E, Haduch A, Liskova B, Wójcikowski J, Daniel WA. Biochem Pharmacol. 2016 Jul 15;112:82-9. doi: 10.1016/j.bcp.2016.04.017


Publications (Impact Factor Journals):